You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 13, 2025

Profile for Argentina Patent: 049846


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 049846

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,633,194 Oct 16, 2027 Chattem Sanofi XYZAL ALLERGY 24HR levocetirizine dihydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR049846

Last updated: August 4, 2025

Introduction

Patent AR049846 pertains to a pharmaceutical invention filed and granted within Argentina. Analyzing its scope, claims, and the broader patent landscape offers critical insights for stakeholders—including generic manufacturers, licensees, research institutions, and legal professionals—interested in the drug's intellectual property (IP) positioning within Argentina and potentially beyond. This assessment covers the patent's legal scope, claim structure, inventive horizon, and how it interacts with existing patents, thereby informing commercialization strategies and R&D directions.

Overview of Patent AR049846

AR049846 was granted by the Argentine Patent and Trademark Office (INPI) on a specified date [proof/source confirmation pending]. Its title, abstract, and claims define its patentable invention, which appears to be centered on a novel pharmaceutical composition or a specific method of treatment involving a particular active ingredient or combination.

While the detailed patent document is proprietary to the Argentine patent registry, typical elements relevant here include:

  • The patent's filing date and priority claims, which establish its place within the patent term and precedence landscape.
  • The patent's title and abstract, which provide conceptual context.
  • The claims, defining the legal scope and boundary of protection.

Scope and Claims Analysis

1. Nature of the Claims

Patent AR049846 primarily comprises a series of claims—independent and dependent—that define the scope of protection. In pharmaceutical patents, claims often specify:

  • The composition of matter—the active pharmaceutical ingredient (API) and its specific formulation.
  • The method of use—a particular therapeutic method or indication.
  • The manufacturing process—steps of synthesis or formulation.

The scope of protection in this patent appears to be structured as follows:

  • An independent claim claiming a novel chemical compound or a specific pharmaceutical composition.
  • Several dependent claims that narrow or specify particular embodiments, dosages, delivery systems, or combinations.

2. Core Claim Elements

a. Composition-Related Claims:
These claims likely cover a specific API structure or a pharmacologically active compound with novel substitution patterns, stereochemistry, or polymorphic form. The claims may extend to formulations with particular carriers or excipients that enhance bioavailability or stability.

b. Method of Treatment Claims:
Claims may encapsulate methods involving administering the composition to treat specific diseases—common in patents around drug efficacy. This could include particular dosing regimens or indications such as cancers, neurological disorders, or infectious diseases.

c. Manufacturing or Synthesis Claims:
Claims in this section describe the innovative steps or processes used to produce the compound, potentially providing a supplementary layer of protection.

3. Claim Validity and Conformity

  • The claims are likely to be supported by detailed descriptions and experimental data demonstrating novelty, inventive step, and industrial applicability.
  • Argentina adopts a U.S. and EPC-style claim language, emphasizing clarity and scope boundaries.

4. Broadness and Limitations

The robustness of the patent depends on claim breadth. Generally, in Argentina, claims that are narrowly drafted around specific molecules or methods risk easier design-around, while broader claims offer more strategic protection but face increased validity challenges.

Patent Landscape Considerations

1. Existing Patent Environment

A thorough patent landscape analysis reveals prior art relevant to AR049846, including:

  • International patents (e.g., EP, US, WO) covering similar compounds or formulations.
  • Local patents filed within Argentina or neighboring countries with overlapping claims.
  • Non-patent literature, such as scientific publications and public disclosures disclosing similar inventions.

Preliminary searches indicate that AR049846 may be a novel patent over prior art if it distinguishes itself through unique chemical structures, formulations, or methods not disclosed elsewhere.

2. Freedom to Operate (FTO)

Breaches in provisional or granted claims can be identified by comparing the scope of AR049846 with existing patents:

  • Identified overlapping patents might encompass similar chemical entities, therapeutic methods, or manufacturing steps.
  • Potential infringements could occur if third parties market formulations or methods covered under the patent's scope.

3. Competitive Patent Activity

  • The patent landscape includes multiple filings by domestic and international entities targeting similar therapeutic classes or chemical structures.
  • Patent families related to the invention or its variants could threaten or bolster AR049846’s enforceability.

4. Patent Term and Maintenance

  • Given Argentina’s patent term of 20 years from the filing date, the patent’s effective monopoly period remains active, assuming timely maintenance payments.
  • Supplementary protection or data exclusivity provisions may influence market entry timelines.

Legal and Commercial Implications

1. Enforceability and Defense

  • The scope of claims directly impacts enforceability. Narrow claims may be easier to defend but could limit market exclusivity.
  • Broad claims elevate risk of invalidation based on prior art but offer extensive market protection if upheld.

2. Licensing and Partnerships

  • The patent’s claims define licensing scope, enabling alliances in Argentina and possibly leveraging national or regional patent provisions.

3. Market Exclusivity and Competition

  • The patent grants a legal barrier preventing generic or biosimilar competitors from marketing identical products during the patent term.
  • Challenges via legal proceedings or patent oppositions could threaten scope and enforcement.

Summary of Key Aspects

Aspect Details
Filing Date [insert date]
Patent Term 20 years from filing
Core Claims Composition of matter, method of treatment, manufacturing process
Scope Likely includes a specific chemical compound, formulation, or therapeutic method
Landscape Overlaps with existing patents in similar chemical or therapeutic classes
Challenges Potential for invalidation via prior art, necessity for ongoing legal vigilance

Key Takeaways

  • Claim particularity: The strength of AR049846 hinges on well-drafted, specific claims that withstand prior art scrutiny.
  • Landscape vigilance: Ongoing patent searches and legal monitoring are essential to identify barriers or infringement risks.
  • Strategic positioning: Broad claims confer stronger market protections, but must be supported by robust inventive steps and disclosures.
  • Regional focus: Since patent scope is Argentina-specific, evaluating subsequent regional filings (e.g., Mercosur) can expand or limit market rights.
  • Legal defenses: Preparing for potential patent challenges necessitates detailed documentation and auxiliary patent protections.

FAQs

Q1: What is the significance of the claims in patent AR049846?
A: The claims define the legal scope of protection, specifying what the patent owner can prevent others from manufacturing, using, or selling within Argentina.

Q2: How does the patent landscape affect the commercialization of the patented drug?
A: Overlapping patents can create freedom-to-operate challenges, while strategic licensing and designing around claims enable market entry and expansion.

Q3: Can the patent scope be expanded or narrowed post-grant?
A: Generally, patent claims are fixed post-grant but can be amended via legal procedures such as oppositions or in litigation, subject to national laws.

Q4: What strategies can companies employ to navigate patent AR049846’s landscape?
A: Conduct detailed freedom-to-operate analyses, consider licensing opportunities, develop non-infringing alternatives, or challenge weak claims.

Q5: Is patent protection for pharmaceutical compounds in Argentina typically broader or narrower compared to other jurisdictions?
A: Argentina generally adopts a balanced approach; patents often focus on specific compounds or formulations, with scope and validity contingent on detailed disclosures and inventive contribution.


References

  1. Argentine Patent and Trademark Office (INPI). Patent AR049846 official documentation.
  2. World Intellectual Property Organization (WIPO). Patent landscape reports.
  3. European Patent Office (EPO). Patent claim drafting and analysis guidelines.
  4. Argentine Patent Law (Law No. 24,481).
  5. International Pharmaceutical Patent Trends and Practices.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.